Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,185.84
1,862.19
2,282.82
2,499.66
2,280.16
2,003.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,185.84
1,862.19
2,282.82
2,499.66
2,280.16
2,003.79
Raw Material Cost
1,304.57
1,183.56
1,457.82
1,440.69
1,062.29
999.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
615.65
606.19
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.95
3.28
8.05
13.64
14.07
14.22
Selling and Distribution Expenses
169.27
156.55
163.62
140.11
121.53
137.93
Other Expenses
-52.94
-50.99
7.84
4.32
3.37
3.23
Total Expenditure (Excl Depreciation)
1,565.03
1,439.73
1,707.93
1,637.63
1,231.54
1,184.25
Operating Profit (PBDIT) excl Other Income
620.8
422.5
574.9
862
1048.6
819.5
Other Income
156.37
158.73
158.85
33.21
16.00
57.16
Operating Profit (PBDIT)
930.66
709.16
859.59
1,010.76
1,161.61
953.93
Interest
4.95
3.28
8.05
13.64
14.07
14.22
Exceptional Items
1.63
-0.19
3.47
-7.67
-3.29
-3.08
Gross Profit (PBDT)
881.27
678.62
825.00
1,058.97
1,217.86
1,003.96
Depreciation
155.54
140.14
129.15
116.08
97.53
80.03
Profit Before Tax
771.80
565.55
725.85
873.37
1,046.73
856.60
Tax
120.55
89.32
103.64
129.49
159.64
128.89
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
651.22
475.85
622.12
743.89
887.09
727.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
651.22
475.85
622.12
743.89
887.09
727.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
651.22
475.85
622.12
743.89
887.09
727.72
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,615.89
4,232.95
4,057.98
1,908.70
1,154.87
1,321.65
Earnings per share (EPS)
1.49
1.09
1.42
1.7
2.03
1.66
Diluted Earnings per share
1.49
1.09
1.42
1.7
2.03
1.66
Operating Profit Margin (Excl OI)
28.31%
22.03%
25.04%
34.46%
45.97%
40.76%
Gross Profit Margin
42.42%
37.9%
37.45%
39.58%
50.18%
46.74%
PAT Margin
29.79%
25.55%
27.25%
29.76%
38.9%
36.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 17.38% vs -18.42% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 36.84% vs -23.50% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 40.68% vs -21.45% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 51.52% vs -59.26% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of JiangXi Tianxin Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,185.84
0
2,185.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,185.84
0
2,185.84
Raw Material Cost
1,304.57
0
1,304.57
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
615.65
0
615.65
Power Cost
0
0
0.00
Manufacturing Expenses
4.95
0
4.95
Selling and Distribution Expenses
169.27
0
169.27
Other Expenses
-52.94
0.00
-52.94
Total Expenditure (Excl Depreciation)
1,565.03
0
1,565.03
Operating Profit (PBDIT) excl Other Income
620.82
0.00
620.82
Other Income
156.37
0
156.37
Operating Profit (PBDIT)
930.66
0
930.66
Interest
4.95
0
4.95
Exceptional Items
1.63
0
1.63
Gross Profit (PBDT)
881.27
0
881.27
Depreciation
155.54
0
155.54
Profit Before Tax
771.80
0
771.80
Tax
120.55
0
120.55
Provisions and contingencies
0
0
0.00
Profit After Tax
651.22
0
651.22
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
651.22
0
651.22
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
651.22
0
651.22
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,615.89
0
4,615.89
Earnings per share (EPS)
1.49
0
1.49
Diluted Earnings per share
1.49
0
1.49
Operating Profit Margin (Excl OI)
28.31%
0%
0.00
28.31%
Gross Profit Margin
42.42%
0%
0.00
42.42%
PAT Margin
29.79%
0%
0.00
29.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 218.58 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 17.38% vs -18.42% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 65.12 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 36.84% vs -23.50% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 77.43 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 40.68% vs -21.45% in Dec 2023
Annual - Interest
Interest 0.50 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 51.52% vs -59.26% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.31%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






